The management of superficial candidiasis

Journal of the American Academy of Dermatology

Volumn 40, Issue 6 II, 1999, Pages

  Hay, R J ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; TERBINAFINE;

CANDIDA; CANDIDIASIS; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG SENSITIVITY; HUMAN; MUCOCUTANEOUS CANDIDIASIS; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PARONYCHIA; PRIORITY JOURNAL; SPECIES DIFFERENCE; THRUSH; TOPICAL DRUG ADMINISTRATION; VAGINA CANDIDIASIS;

EID: 0033039466     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70396-8     Document Type: Conference Paper

References (46)

1. FC. Odds Candida and candidiasis 1988 : Bailliere Tindall London
2. JD. Sobel Vulvovaginal candidiasis: what we do and do not know Ann Intern Med 101 1984 390 392
3. J Torssander L Morfeldt-Manson G Biberfeld A Karlsson PO Putkonen J. Wasserman Oral Candida albicans in HIV infection Scand J Dis 19 1987 291 295
4. RY Lin P. Goodhart The role of oral candidiasis in survival and hospitalization patterns: analysis of an inner city hospital immunodeficiency virus/acquired immune deficiency syndrome registry Am J Med Sci 306 1993 345 353
5. WG Powderly K Robinson EJ. Keath Molecular epidemiology of recurrent oral andidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence J Infect Dis 168 1993 463 466
6. + lymphocytes among injection drug users infected with the human immunodeficiency virus Am J Epidemiol 137 1993 989 1000
7. LJ Conley TJ Bush SP Buchbinder KA Penley FN Judson SD. Holmberg The association between cigarette smoking and selected HIV-related medical conditions AIDS 10 1996 1121 1126
8. F Dronda M Alonso-Sanz F Laguna F Chaves JV Martinez-Suarez JL Rodriguez-Tudela Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients Eur J Clin Microbiol Infect Dis 15 1996 446 452
9. DJ Sullivan MC Henman GP Moran LC O’Neill DE Bennett DB Shanley Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species J Med Microbiol 44 1996 399 408
10. MA Pfaller J Rhine-Chalberg SW Redding J Smith G Farinacci AW Fothergill Variations in fluconazole susceptibility and electrophorectic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis J Clin Microbiol 32 1994 59 64
11. RJ. Hay Antifungal therapy of yeast infections J Am Acad Dermatol 31 1994 S6 S9
12. JR Maenza WG Merz MJ Romagnoli JC Keruly RD Moore JE. Gallant Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology Clin Infect Dis 24 1997 28 34
13. SG Revankar WR Kirkpatrick RK McAtee OP Dib AW Fothergill SW Redding Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients J Infect Dis 174 1996 821 827
14. R Le Guennec J Reynes M Mallie C Pujol F Janbon JM. Bastide Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities J Clin Microbiol 33 1995 2732 2737
15. JH Rex MA Pfaller AL Barry PW Nelson CD. Webb Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia Antimicrob Agents Chemother 39 1995 40 44
16. EM Johnson KG Davey A Szekely DW. Warnock Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species J Antimicrob Chemother 36 1995 787 793
17. DC Lamb DE Kelly NJ Manning SL Kelly Reduced intracellular accumulation of role antifungal results in resistance in Candida albicans isolate NCPF 3363 FEMS Microbiol Lett 147 1997 189 193
18. RJ Hay R Baran MK Moore JD. Wilkinson Candida onychomycosis: an evaluation of the role of Candida species in nail disease Br J Dermatol 118 1988 47 58
19. H Nsanze GG Lestringant N Mustafa MA. Usmani Aetiology of onychomycosis in Al Ain, United Arab Emirates Mycoses 38 1995 421 424
20. D Greenspan JS. Greenspan Oral mucosal manifestations of AIDS Dermatol Clin 5 1987 733 737
21. BED. Cooke Median rhomboid glossitis: candidiasis and not a developmental anomaly Br J Dermatol 93 1975 399 405
22. LP Samaranayake HB. Yaacob Classification of oral candidiasis LP Samaranayake TW MacFarlane Oral candidiasis. 1990 : Wright London 82 101
23. AG Prentice DW Wamock SA Johnson PC Taylor DA. Oliver Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukemia J Antimicrob Chemother 36 1995 657 663
24. P Phillips J Zemcov W Mahmood JS Montaner K Craib AM. Clarke Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility AIDS 10 1996 1369 1376
25. C Drobacheff A Manteaux L Millon G Reboux T Barale R. Laurent Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV [in French] Ann Dermatol Venereol 123 1996 85 89
26. S Silverman Jr JW Gallo ML McKnight P Mayer S deSanz MM. Tan Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82 1996 402 407
27. M Tumbarello G Caldarola E Tacconelli G Morace B Posteraro R Cauda Analysis of the risk factors associated with the emergence of azole resistant oral candidiasis in the course of HIV infection J Antimicrob Chemother 38 1996 691 699
28. Y Kulak A Arikan N. Delibalta Comparison of three different treatment methods for generalized denture stomatitis J Prosthet Dent 72 1994 283 288
29. AM Geiger B. Foxman Risk factors for vulvovaginal candidiasis: a case-control study among university students Epidemiology 7 1996 182 187
30. AM Geiger B Foxman JD. Sobel Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida Genitourin Med 71 1995 304 307
31. S. Faro Vaginitis: diagnosis and management Int J Fertil Menopausal Stud 41 1996 115 123
32. DG Ferris C Dekle MS Litaker Women’s use of over-the-counter antifungal medications for gynecologic symptoms J Fam Pract 42 1996 595 600
33. PL Fidel Jr NA Wolf MA. KuKuruga T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery Infect Immun 64 1996 3793 3799
34. JD. Sobel Recurrent vulvovaginal candidiasis N Engl J Med 315 1986 1455 1458
35. V Kunzelmann HJ Tietz D Rossner V Czaika M Hopp A Schmalreck Prerequisites for effective therapy of chronic recurrent vaginal candidiasis Mycoses 39 suppl 1996 65 72 [in German]
36. ME Lynch JD Sobel PL Fidel Jr. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis J Med Vet Mycol 34 1996 337 339
37. DJ White EM Johnson DW. Wamock Management of persistent vulvovaginal candidiasis due to azole-resistant Candida glabrata Genitourin Med 69 1993 112 114
38. JD Sobel W Chaim D. Leaman Recurrent vulvovaginal candidiasis associated with long-term tamoxifen treatment in postmenopausal women Obstet Gynecol 88 1996 704 706
39. Guidelines/Outcome Committee American Academy of Dermatology Guidelines of care for superficial mycotic infections of the skin: mucocutaneous candidiasis J Am Acad Dermatol 34 1996 110 115
40. W Frain-Bell Chronic paronychia: short review of 590 cases Trans St John’s Hosp Dermatol Soc 38 1957 29 30
41. CH Kirkpatrick RB Rich JE. Bennett Chronic mucocutaneous candidiasis: model building in cellular immunology Ann Intern Med 74 1971 955 978
42. SR Porter C. Scully Candida endocrinopathy syndrome Oral Surg Oral Med Oral Pathol 61 1986 573 578
43. R Coleman RJ. Hay Chronic mucocutaneous candidiasis associated with hypothyroidism: A distinct syndrome? Br J Dermatol 136 1997 24 29
44. CH. Kirkpatrick Chronic mucocutaneous candidiasis J Am Acad Dermatol 31 1994 S14 S17
45. D Lilic JE Calvert AJ Cant M Abinun GP. Spickett Chronic mucocutaneous candidiasis, II: class and subclass of specific antibody responses in vivo and in vitro Clin Exp Immunol 105 1996 213 219
46. M Masi C De Vinci OR. Baricordi Transfer factor in chronic mucocutaneous candidiasis Biotherapy 9 1996 97 103